Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Rebecca Lever studied pharmacy at King’s College London, followed by pre-registration training in hospital pharmacy, before returning to King’s to undertake a PhD in pharmacology under the supervision of Professor Clive Page.
I am an academic and researcher working as a pharmacologist and immunopharmacologist mainly in the field of allergy.
Dave Lewis was awarded a BSc in Pharmacology (University of Leeds) and a PhD from the University of Birmingham.
Dr Lewis obtained his BA from Trinity College Cambridge, England in medical sciences and biochemistry and did his clinical training at the University of Wales College of Medicine graduating MBBCh in 1977.
Vincenzo Libri is Professor of Translational Neurology at University College London-Institute of Neurology and Consultant in Clinical Pharmacology at UCLH-National Hospital for Neurology and Neurosurgery.
Elliot is a Senior Scientific Officer within the RSPCA Research Animals Department, which works to achieve more effective ethical review of animal use and implementation of the Three Rs.
Dr Yoon K Loke is Professor of Medicine and Pharmacology at the University of East Anglia, and Convenor of the Cochrane Adverse Effects Methods Group.